Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

531 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry).
Cortese B, Ielasi A, Moscarella E, Loi B, Tarantini G, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Varricchio A, Tespili M, Latini RA, Defilippi G, Corrado D, Steffenino G; RAI Investigators. Cortese B, et al. Among authors: moretti l. Am J Cardiol. 2017 Jun 15;119(12):1924-1930. doi: 10.1016/j.amjcard.2017.03.017. Epub 2017 Mar 29. Am J Cardiol. 2017. PMID: 28438304 Clinical Trial.
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).
Tarantini G, Mojoli M, Masiero G, Cortese B, Loi B, Varricchio A, Gabrielli G, Durante A, Pasquetto G, Calabrò P, Gistri R, Tumminello G, Misuraca L, Pisano F, Ielasi A, Mazzarotto P, Coscarelli S, Lucci V, Moretti L, Nicolino A, Colombo A, Olivari Z, Fineschi M, Piraino D, Piatti L, Canosi U, Tellaroli P, Corrado D, Rovera C, Steffenino G; all RAI investigators. Tarantini G, et al. Among authors: moretti l. Catheter Cardiovasc Interv. 2018 Jan 1;91(1):E1-E16. doi: 10.1002/ccd.27095. Epub 2017 May 13. Catheter Cardiovasc Interv. 2018. PMID: 28500737
One-year clinical outcomes after unrestricted implantation of the Absorb bioresorbable scaffold (RAI registry).
Ielasi A, Cortese B, Moscarella E, Loi B, Tarantini G, Varricchio A, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Tespili M, Orrego PS, Corrado D, Steffenino G. Ielasi A, et al. Among authors: moretti l. EuroIntervention. 2018 Aug 3;14(5):e546-e553. doi: 10.4244/EIJ-D-17-00443. EuroIntervention. 2018. PMID: 28966155 Free article.
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry).
Moscarella E, Ielasi A, Varricchio A, De Angelis MC, Loi B, Tarantini G, Calabrò P, Cortese B, Mazzarotto P, Gabrielli G, Pisano F, Facchin M, Misuraca L, Lucci V, Gistri R, Tumminello G, Moretti L, Colombo A, Durante A, Fineschi M, Piraino D, Ferrario M, Coscarelli S, Nicolino A, Tespili M, Corrado D, Steffenino G. Moscarella E, et al. Among authors: moretti l. Int J Cardiol. 2018 May 1;258:50-54. doi: 10.1016/j.ijcard.2018.01.135. Epub 2018 Feb 3. Int J Cardiol. 2018. PMID: 29429635 Clinical Trial.
"Full-plastic jacket" with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413).
Tarantini G, Masiero G, Fovino LN, Mojoli M, Varricchio A, Loi B, Gistri R, Misuraca L, Gabrielli G, Cortese B, Pisano F, Moretti L, Tumminello G, Olivari Z, Mazzarotto P, Colombo A, Calabrò P, Nicolino A, Tellaroli P, Corrado D, Durante A, Steffenino G; all RAI investigators. Tarantini G, et al. Among authors: moretti l. Int J Cardiol. 2018 Sep 1;266:67-74. doi: 10.1016/j.ijcard.2018.01.063. Int J Cardiol. 2018. PMID: 29887475 Clinical Trial.
One-year clinical performance of ABSORB bioresorbable vascular scaffold in patients presenting with acute coronary syndromes: Results from the RAI registry.
Moscarella E, Ielasi A, Varricchio A, Cortese B, Loi B, Tarantini G, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Tespili M, Silva Orrego P, Corrado D, Steffenino G; RAI Investigators. Moscarella E, et al. Among authors: moretti l. Catheter Cardiovasc Interv. 2019 Feb 15;93(3):404-410. doi: 10.1002/ccd.27845. Epub 2018 Oct 22. Catheter Cardiovasc Interv. 2019. PMID: 30346080
High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study.
Cristell N, Cianflone D, Durante A, Ammirati E, Vanuzzo D, Banfi M, Calori G, Latib A, Crea F, Marenzi G, De Metrio M, Moretti L, Li H, Uren NG, Hu D, Maseri A; FAMI Study Investigators. Cristell N, et al. Among authors: moretti l. J Am Coll Cardiol. 2011 Dec 13;58(25):2654-61. doi: 10.1016/j.jacc.2011.08.055. J Am Coll Cardiol. 2011. PMID: 22152952 Free article.
Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial.
Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, Frisinghelli A, Minneci C, Valisi M, Maggioni AP, Marchioli R, Tognoni G, Tavazzi L; GISSI-HF Investigators. Masson S, et al. Among authors: moretti l. Circ Heart Fail. 2010 Jan;3(1):65-72. doi: 10.1161/CIRCHEARTFAILURE.109.881805. Epub 2009 Oct 22. Circ Heart Fail. 2010. PMID: 19850697 Clinical Trial.
531 results